Full Text View
Tabular View
No Study Results Posted
Related Studies
WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction
This study is ongoing, but not recruiting participants.
Study NCT01636726   Information provided by GlaxoSmithKline

First Received on July 5, 2012.   Last Updated on July 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Chronic Disease
Infarction
Lung Diseases
Myocardial Infarction
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Cardiovascular Diseases
Disease Attributes
Heart Diseases
Ischemia
Lung Diseases, Obstructive
Myocardial Ischemia
Necrosis
Pathologic Processes
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Inhaled LABA use
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services